Welcome to LookChem.com Sign In|Join Free
  • or
N-(4-methyl-3-nitrophenyl)-4-(4-methylpiperazin-1-ylmethyl)-3-trifluoromethylbenzamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1616689-72-5

Post Buying Request

1616689-72-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1616689-72-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1616689-72-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,1,6,6,8 and 9 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1616689-72:
(9*1)+(8*6)+(7*1)+(6*6)+(5*6)+(4*8)+(3*9)+(2*7)+(1*2)=205
205 % 10 = 5
So 1616689-72-5 is a valid CAS Registry Number.

1616689-72-5Downstream Products

1616689-72-5Relevant academic research and scientific papers

Design, synthesis and optimization of bis-amide derivatives as CSF1R inhibitors

Ramachandran, Sreekanth A.,Jadhavar, Pradeep S.,Miglani, Sandeep K.,Singh, Manvendra P.,Kalane, Deepak P.,Agarwal, Anil K.,Sathe, Balaji D.,Mukherjee, Kakoli,Gupta, Ashu,Haldar, Srijan,Raja, Mohd,Singh, Siddhartha,Pham, Son M.,Chakravarty, Sarvajit,Quinn, Kevin,Belmar, Sebastian,Alfaro, Ivan E.,Higgs, Christopher,Bernales, Sebastian,Herrera, Francisco J.,Rai, Roopa

, p. 2153 - 2160 (2017)

Signaling via the receptor tyrosine kinase CSF1R is thought to play an important role in recruitment and differentiation of tumor-associated macrophages (TAMs). TAMs play pro-tumorigenic roles, including the suppression of anti-tumor immune response, promotion of angiogenesis and tumor cell metastasis. Because of the role of this signaling pathway in the tumor microenvironment, several small molecule CSF1R kinase inhibitors are undergoing clinical evaluation for cancer therapy, either as a single agent or in combination with other cancer therapies, including immune checkpoint inhibitors. Herein we describe our lead optimization effort that resulted in the identification of a potent, cellular active and orally bioavailable bis-amide CSF1R inhibitor. Docking and biochemical analysis allowed the removal of a metabolically labile and poorly permeable methyl piperazine group from an early lead compound. Optimization led to improved metabolic stability and Caco2 permeability, which in turn resulted in good oral bioavailability in mice.

AZAINDOLE DERIVATIVES AS MULTI KINASE INHIBITORS

-

Page/Page column 66, (2014/07/21)

The present invention relates to compounds of the following formula (I) and/or the pharmaceutically acceptable addition salts, solvates, enantiomers, diastereoisomers thereof, as well as mixtures thereof. The subject matter of the present invention thus also includes the preparation of compounds of formula (I), their uses, in particular in the inhibition of protein kinases which are implicated for example in numerous diseases such as cancers or immune system disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1616689-72-5